These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 26814615

  • 1. Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.
    Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Di Benedetto P, Cipriani P, Giacomelli R, Gerli R.
    Clin Exp Immunol; 2016 Jun; 184(3):284-92. PubMed ID: 26814615
    [Abstract] [Full Text] [Related]

  • 2. IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.
    Alunno A, Bistoni O, Bartoloni Bocci E, Caterbi S, Bigerna B, Pucciarini A, Tabarrini A, Mannucci R, Beghelli D, Falini B, Gerli R.
    Reumatismo; 2013 Oct 31; 65(4):192-8. PubMed ID: 24192564
    [Abstract] [Full Text] [Related]

  • 3. IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome.
    Alunno A, Bistoni O, Bartoloni E, Caterbi S, Bigerna B, Tabarrini A, Mannucci R, Falini B, Gerli R.
    Ann Rheum Dis; 2013 Feb 31; 72(2):286-92. PubMed ID: 22904262
    [Abstract] [Full Text] [Related]

  • 4. Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.
    Ciccia F, Guggino G, Rizzo A, Alessandro R, Carubbi F, Giardina A, Cipriani P, Ferrante A, Cannizzaro A, Giacomelli R, Triolo G.
    Rheumatology (Oxford); 2014 Jul 31; 53(7):1313-20. PubMed ID: 24602921
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
    Ciccia F, Accardo-Palumbo A, Alessandro R, Alessandri C, Priori R, Guggino G, Raimondo S, Carubbi F, Valesini G, Giacomelli R, Rizzo A, Triolo G.
    Clin Exp Immunol; 2015 Aug 31; 181(2):230-8. PubMed ID: 25902739
    [Abstract] [Full Text] [Related]

  • 6. CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.
    Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Bigerna B, Pacini R, Beghelli D, Cipriani P, Giacomelli R, Gerli R.
    J Autoimmun; 2014 Jun 31; 51():38-43. PubMed ID: 24461537
    [Abstract] [Full Text] [Related]

  • 7. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
    Delli K, Haacke EA, Kroese FG, Pollard RP, Ihrler S, van der Vegt B, Vissink A, Bootsma H, Spijkervet FK.
    Ann Rheum Dis; 2016 Nov 31; 75(11):1933-1938. PubMed ID: 26757748
    [Abstract] [Full Text] [Related]

  • 8. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
    Verstappen GM, Kroese FG, Meiners PM, Corneth OB, Huitema MG, Haacke EA, van der Vegt B, Arends S, Vissink A, Bootsma H, Abdulahad WH.
    J Rheumatol; 2017 Jan 31; 44(1):49-58. PubMed ID: 28042126
    [Abstract] [Full Text] [Related]

  • 9. Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome.
    Alunno A, Ibba-Manneschi L, Bistoni O, Rosa I, Caterbi S, Gerli R, Manetti M.
    J Cell Mol Med; 2016 Apr 31; 20(4):613-22. PubMed ID: 26828975
    [Abstract] [Full Text] [Related]

  • 10. FcRL4+ B-cells in salivary glands of primary Sjögren's syndrome patients.
    Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM, Kroese FGM.
    J Autoimmun; 2017 Jul 31; 81():90-98. PubMed ID: 28390747
    [Abstract] [Full Text] [Related]

  • 11. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A, Kruize AA, Wenting M, Versnel MA, Bijlsma JW, Lafeber FP, van Roon JA.
    Ann Rheum Dis; 2012 Jun 31; 71(6):1027-33. PubMed ID: 22312161
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F, Cipriani P, Marrelli A, Benedetto P, Ruscitti P, Berardicurti O, Pantano I, Liakouli V, Alvaro S, Alunno A, Manzo A, Ciccia F, Gerli R, Triolo G, Giacomelli R.
    Arthritis Res Ther; 2013 Oct 30; 15(5):R172. PubMed ID: 24286296
    [Abstract] [Full Text] [Related]

  • 13. Anti-CD20 antibody in primary Sjögren's syndrome management.
    Chen S, Liu Y, Shi G.
    Curr Pharm Biotechnol; 2014 Oct 30; 15(6):535-41. PubMed ID: 25213362
    [Abstract] [Full Text] [Related]

  • 14. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
    Skarstein K, Jensen JL, Galtung H, Jonsson R, Brokstad K, Aqrawi LA.
    Autoimmunity; 2019 Oct 30; 52(7-8):242-250. PubMed ID: 31661985
    [Abstract] [Full Text] [Related]

  • 15. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity.
    Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM.
    J Autoimmun; 2018 Feb 30; 87():16-25. PubMed ID: 29191572
    [Abstract] [Full Text] [Related]

  • 16. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
    Cornec D, Costa S, Devauchelle-Pensec V, Jousse-Joulin S, Marcorelles P, Berthelot JM, Chiche L, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Saraux A, Pers JO.
    J Autoimmun; 2016 Feb 30; 67():102-110. PubMed ID: 26688003
    [Abstract] [Full Text] [Related]

  • 17. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
    Lisi S, Sisto M, D'Amore M, Lofrumento DD.
    Int Immunol; 2015 Apr 30; 27(4):183-94. PubMed ID: 25381666
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
    Gong YZ, Nititham J, Taylor K, Miceli-Richard C, Sordet C, Wachsmann D, Bahram S, Georgel P, Criswell LA, Sibilia J, Mariette X, Alsaleh G, Gottenberg JE.
    J Autoimmun; 2014 Jun 30; 51():57-66. PubMed ID: 24411167
    [Abstract] [Full Text] [Related]

  • 19. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
    Hamza N, Bootsma H, Yuvaraj S, Spijkervet FK, Haacke EA, Pollard RP, Visser A, Vissink A, Kallenberg CG, Kroese FG, Bos NA.
    Ann Rheum Dis; 2012 Nov 30; 71(11):1881-7. PubMed ID: 22615459
    [Abstract] [Full Text] [Related]

  • 20. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
    Lucchesi D, Coleby R, Pontarini E, Prediletto E, Rivellese F, Hill DG, Derrac Soria A, Jones SA, Humphreys IR, Sutcliffe N, Tappuni AR, Pitzalis C, Jones GW, Bombardieri M.
    Arthritis Rheumatol; 2020 Sep 30; 72(9):1559-1570. PubMed ID: 32307922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.